Michael P Marks Selected Research

Michael P Marks Research Topics

43	Stroke (Strokes) 10/2022 - 03/2005
35	Ischemic Stroke 10/2022 - 07/2005
12	Infarction (Infarctions) 01/2022 - 04/2014
8	Hemorrhage 01/2022 - 10/2005
5	Intracranial Aneurysm (Cerebral Aneurysm) 08/2019 - 04/2011
5	Aneurysm (Aneurysms) 08/2019 - 09/2003
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 07/2016
3	Thrombosis (Thrombus) 01/2021 - 05/2007
3	Ischemia 05/2007 - 09/2003
2	Clinical Deterioration 01/2020 - 07/2014
2	Cerebral Infarction 01/2019 - 10/2014
2	Intracranial Vasospasm 01/2015 - 09/2012
2	Pathologic Constriction (Stenosis) 02/2012 - 03/2005
1	Atrial Fibrillation 10/2022
1	Body Weight (Weight, Body) 01/2021
1	Brain Edema (Cerebral Edema) 01/2021
1	Inflammation (Inflammations) 08/2019
1	Foreign-Body Reaction 08/2019
1	Hematoma 05/2015
1	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 09/2011
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2010
1	Cerebral Hemorrhage 08/2007
1	Pica (Geophagia) 05/2007
1	Pain (Aches) 08/2005
1	Compression Fractures (Compression Fracture) 08/2005
1	Transient Ischemic Attack 03/2005
1	Vertebrobasilar Insufficiency 02/2005

6	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2022 - 07/2005
2	GadoliniumIBA 01/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2019
2	Cytidine Triphosphate (CTP)IBA 01/2021 - 01/2018
2	XenonIBA 02/2016 - 06/2010
1	AnticoagulantsIBA 10/2022
1	PolymersIBA 08/2019
1	Phenobarbital (Luminal)FDA Link 11/2017
1	Heparin (Liquaemin)FDA LinkGeneric 07/2014
1	Nicardipine (Dagan)FDA LinkGeneric 09/2012
1	PCA 10IBA 05/2007
1	Analgesics (Analgesic Drugs)IBA 08/2005